• Fast Test Solution at Centre of Finnish Research

News & Views

Fast Test Solution at Centre of Finnish Research

May 18 2020

Development of a rapid test for the coronavirus has been commenced by VTT Technical Research Centre of Finland together with MeVac, the joint vaccine research centre of the Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki.

Based on detecting the viral antigens of the COVID-19 virus, the test will provide healthcare professionals with an accurate, fast and resource-efficient method to detect coronavirus infections early. “As the situation with the epidemic began to worsen internationally, we started looking for solutions within our area of excellence,”  said Dr. Leena Hakalahti, the head of a research team on biosensors at VTT. “We have expertise in antibody development and production, as well as previous experience in designing diagnostic tests. It was an easy decision for us to start working on the COVID-19 antibody.”

Initially designed for use by healthcare personnel it is expected to yield results in 15 minutes or less, which is significantly faster than existing tests.  The first versions of the test are expected this autumn.

“As the research progresses, we will explore the possibility of using the developed antibodies not only for testing, but also for the treatment of the coronavirus disease,” said Olli Vapalahti, professor of virology at the University of Helsinki.

Once the technology has been completed, the same development process could be quickly applied to diagnose also other viruses. The team is actively seeking Finnish companies to join the co-operation, along with additional funding.


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events